[Modulators of oncogene product functions].
Umezawa
K
K
Department of Applied Chemistry, Faculty of Science and Technology, Keio University, Yokohama, Japan.
D001419:Bacteria / Q000378:metabolism; D005658:Fungi / Q000378:metabolism; D005663:Furans / Q000302:isolation & purification / Q000494:pharmacology; D019204:GTP-Binding Proteins / Q000037:antagonists & inhibitors; D006873:Hydroquinones / Q000302:isolation & purification / Q000494:pharmacology*; D008148:Lovastatin / Q000031:analogs & derivatives / Q000302:isolation & purification / Q000494:pharmacology; D014442:Monophenol Monooxygenase / Q000037:antagonists & inhibitors; D015513:Oncogene Proteins / Q000037:antagonists & inhibitors*; D010636:Phenols / Q000302:isolation & purification / Q000494:pharmacology*; D010716:Phosphatidylinositols / Q000037:antagonists & inhibitors; D010944:Plants / Q000378:metabolism; D012263:Ribonucleosides / Q000302:isolation & purification / Q000494:pharmacology
D005663:Furans; D006873:Hydroquinones; D015513:Oncogene Proteins; D010636:Phenols; D010716:Phosphatidylinositols; D012263:Ribonucleosides; C071861:inostamycin; C012258:mevastatin; C062898:lavendustin A; C032886:oxanosine; D008148:Lovastatin; D014442:Monophenol Monooxygenase; D019204:GTP-Binding Proteins; C048212:erbstatin